AFP and neoplasm: To address these issues, we studied the dynamics of tumor-specific T cells induced by ablative therapy during a specific follow-up period post-ablation using SALL4, MAGE-A1, MAGE-A3, NY-ESO-1, SSX2 and AFP to stimulate the antitumor T cell response.